Lataa...
Anti-GPC3-CAR T Cells Suppress the Growth of Tumor Cells in Patient-Derived Xenografts of Hepatocellular Carcinoma
BACKGROUND: The lack of a general clinic-relevant model for human cancer is a major impediment to the acceleration of novel therapeutic approaches for clinical use. We propose to establish and characterize primary human hepatocellular carcinoma (HCC) xenografts that can be used to evaluate the cytot...
Tallennettuna:
Julkaisussa: | Front Immunol |
---|---|
Päätekijät: | , , , , , , , , , , , , , , , , , , , |
Aineistotyyppi: | Artigo |
Kieli: | Inglês |
Julkaistu: |
Frontiers Media S.A.
2017
|
Aiheet: | |
Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5225101/ https://ncbi.nlm.nih.gov/pubmed/28123387 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2016.00690 |
Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|